| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.5M | — | +6.4% |
| Cost of Revenue | $10.2M | — | +4.5% |
| Gross Profit | $12.2M | — | +8.1% |
| R&D Expense | $4.0M | — | +36.3% |
| SG&A Expense | $9.3M | — | +31.2% |
| Operating Income | -$5.5M | — | -105.6% |
| Interest Expense | $0 | — | -100.0% |
| Pre-tax Income | -$3.3M | — | -209.6% |
| Income Tax | $7K | — | -41.7% |
| Net Income | -$3.3M | — | -210.3% |
| EPS (Basic) | -$0.15 | — | -236.4% |
| EPS (Diluted) | -$0.25 | — | -327.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.5M | -0.0% | +117.4% |
| Accounts Receivable | $19.9M | -13.4% | +20.2% |
| Inventory | $18.2M | +19.0% | +54.0% |
| Current Assets | $82.5M | +0.7% | +70.3% |
| Total Assets | $86.8M | +1.3% | +68.8% |
| Current Liabilities | $48.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | +14.8% |
| Capital Expenditures | $15K | — | +275.0% |
| Investing Cash Flow | -$415K | — | -277.3% |
| Financing Cash Flow | $5.5M | — | +171.2% |
| Free Cash Flow | -$5.1M | — | +14.6% |
| +18.3% |
| Long-term Debt | $1.9M | -20.8% | -49.3% |
| Total Liabilities | $50.9M | +1.5% | -19.7% |
| Stockholders' Equity | $21.0M | +10.3% | +181.4% |